Phase 3 trial of everolimus for metastatic renal cell carcinoma

J. Motzer, Robert; Escudier, Bernard; Oudard, Stéphane; E. Hutson, Thomas; Porta, Camillo; Bracarda, Sergio; Grünwald, Viktor; A. Thompson, John; A. Figlin, Robert; Hollaender, Norbert; Kay, Andrea; Ravaud, Alain; the RECORD‐1 Study Group, for

doi:10.1002/cncr.25219

Public

Phase 3 trial of everolimus for metastatic renal cell carcinoma

Published in Cancer • Jun 14, 2010

Authors:

Robert J. Motzer

Bernard Escudier

Stéphane Oudard

Abstract

BACKGROUND: A phase 3 trial demonstrated superiority at interim analysis for everolimus over placebo in patients with metastatic renal cell carcinoma (mRCC) progressing on vascular endothelial growth factor receptor-tyrosine kinase inhibitors. Final results and analysis of prognostic factors are rep...

Subject

Everolimus

Medicine

Placebo

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!